• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Biotech Market
    Biotech News
    Biotech Stocks
    • Biotech Market
    • Biotech News
    • Biotech Stocks

    Affimed to Present at the Jefferies 2016 London Healthcare Conference

    Chelsea Pratt
    Nov. 09, 2016 02:51AM PST
    Biotech Investing

    Affimed, a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today that Dr. Adi Hoess, CEO, will present at the Jefferies 2016 London Healthcare Conference.

    Affimed N.V. (Nasdaq:AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today that Dr. Adi Hoess, CEO, will present at the Jefferies 2016 London Healthcare Conference on Wednesday, November 16, 2016 at 4:00 p.m. (GMT) in London.

    A live webcast of the conference presentation can be accessed through the “Events” section on the “Media” page of the Affimed website at https://www.affimed.com/events.php. A replay of the presentation will be available from Affimed’s website for 30 days following the conference.

    About Affimed N.V.
    Affimed (Nasdaq:AFMD) engineers targeted immunotherapies, seeking to cure patients by harnessing the power of innate and adaptive immunity (NK- and T-cells). We are developing single and combination therapies to treat cancers and other life-threatening diseases. For more information, please visit www.affimed.com.

    IR Contact:
    Caroline Stewart, Head IR
    Phone: +1 347394 6793
    E-Mail: IR@affimed.com or c.stewart@affimed.com
    Media Contact:
    Anca Alexandru, Head of Communications, EU IR
    Phone: +49 6221 64793341
    E-Mail: a.alexandru@affimed.com

     

    jefferies 2016 healthcare conferencehealthcare conferencegermany
    The Conversation (0)

    Go Deeper

    AI Powered
    AbbVie to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

    AbbVie to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

    AMGEN TO PRESENT AT THE 2025 WELLS FARGO HEALTHCARE CONFERENCE

    AMGEN TO PRESENT AT THE 2025 WELLS FARGO HEALTHCARE CONFERENCE

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Biotech Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×